EPO Patents = 2

Trademarks = 1

Forward Citations = 48

Loading Chart...

8 inventors (with patents filed for the assignee):

Uli Binder (4 out of 4 patents)

Arne Skerra (4 out of 40 patents)

Martin Schlapschy (3 out of 5 patents)

4. Stefan Achatz (1 out of 9 patents)

5. Michaela Gebauer (1 out of 4 patents)

6. Lars Friedrich (1 out of 2 patents)

7. Anne O'Donnell (1 out of 2 patents)

8. Qing Dong (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 11548931 - PASylated VEGFR/PDGFR fusion proteins and their use in therapy (2023-01-10),

2. 11401305 - Nucleic acids encoding repetitive amino acid sequences rich in proline and alanine residues that have low repetitive nucleotide sequences (2022-08-02),

3. 10844094 - Biosynthetic proline/alanine random coil polypeptides and their uses (2020-11-24),

4. 10174302 - Modified L-asparaginase (2019-01-08),

5. 10081657 - Biosynthetic proline/alanine random coil polypeptides and their uses (2018-09-25),

6. 9221882 - Biosynthetic proline/alanine random coil polypeptides and their uses (2015-12-29),

Company Overview

XL-protein GmbH is a biopharmaceutical company specializing in the development of therapeutic proteins with extended plasma half-life. Their proprietary platform technology enables the design and production of long-acting biologics for the treatment of various diseases. The company is dedicated to improving patient outcomes by providing innovative solutions through their innovative protein engineering approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#6 in Freising

#5,401 in Germany

Freising, Germany

Xl-Protein Gmbh

Forward Citations = 48

8 inventors:

Uli Binder (4 out of 4 patents)

Arne Skerra (4 out of 40 patents)

Martin Schlapschy (3 out of 5 patents)

4. Stefan Achatz (1 out of 9 patents)

5. Michaela Gebauer (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Xl-Protein Gmbh. Retrieved from https://idiyas.com/company/xl-protein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]